Enhancing the clinical trial capabilities within Africa is essential to augment the continent’s pandemic prevention, preparedness and response efforts. Here, we describe the critical challenges of clinical trials in Africa and draw upon the lessons learnt from the Consortium for COVID-19 Vaccine Clinical Trials (CONCVACT) experience, such as the importance of regional collaboration, capacity building and establishing standardized protocols.
No takes yet. Share an insight, caveat, or question.
Ndembi et al. (2024) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: